Logo 1 Logo 2

Clinical Trial Details

Trial ID: L3685
Source ID: NCT00814372
Associated Drug: Mbx-102
Title: Evaluate Safety and Effectiveness of MBX-102 in Type 2 Diabetes Patients With Poor Glycemic Control on Metformin
Acronym:
Status: TERMINATED
Study Results: NO
Results:
Conditions: Type 2 Diabetes Mellitus
Interventions: DRUG: MBX-102|DRUG: Placebo|DRUG: Actos|DRUG: Metformin
Outcome Measures: Primary: Change in HbA1c from baseline and compared to placebo, 24 weeks | Secondary: Change in fasting plasma glucose (FPG) from baseline and vs. placebo, 24 weeks
Sponsor/Collaborators: Sponsor: Gilead Sciences
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE2
Enrollment: 242
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Start Date: 2008-12
Completion Date: 2010-02
Results First Posted:
Last Update Posted: 2015-04-17
Locations: Providence Clinical Research, Burbank, California, 91505, United States|American Institute of Research, Los Angeles, California, 90017, United States|Nevada Alliance Against Diabetes, Las Vegas, Nevada, 89101, United States|Piedmont Medical Research Associates, Winston-Salem, North Carolina, 27103, United States|DGD Research, Inc., San Antonio, Texas, 78229, United States|Kamineni Hospitals Pvt, Ltd., Hyderabad, Andhra Pradesh, 50008, India|Bangalore Diabetes Centre, Bangalore, India|Diacon Hospital Diabetes & Research Centre, Bangalore, India|M. S. Ramaiah Memorial Hospital, Bangalore, India|St. John's Medical College & Hospital, Bangalore, India|Dr. V. Seshiah Diabetes Care & Research Institute, Chennai, India|Mediciti Hospital, Hyderabad, India|Medwin Hospital, Hyderabad, India|Diabetes Thyroid Hormone Research Institute Pvt. Ltd., Indore, India|Fortis Hospital, Jaipur, India|Bharti Research Institute of Diabetes & Endocrinology, Karnal, India|Amrita Institute of Medical Sciences, Kochi, India|Diabetes Action Centre, Mumbai, 400067, India|BYL Nair Hospital, Mumbai, India|PD Hindhuja National Hospital, Mumbai, India|Gandhi Endocrinology & Diabetes Centre, Nagpur, India|All India Institute of Medical Sciences, New Delhi, India|Deenanath Mangeshkar Hospital & Research Centre, Pune, India|Diabetes Care & Research Centre, Pune, India|Health & Research Centre, Trivendrum, India|Christian Medical College, Vellore, India
URL: https://clinicaltrials.gov/show/NCT00814372

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress
D089 Metformin small molecule DB00331 Details